Scientist ADME - Hiring in process/Finished, not possible to apply

The Uppsala University Drug Optimization and Pharmaceutical Profiling Platform (UDOPP) is located at the Department of Pharmacy, Uppsala University. The primary aim of UDOPP is to perform in silico and in vitro ADME (Absorption, Distribution, Metabolism and Excretion) investigations of hit collections and compound series during lead optimization in collaboration with academic research groups primarily in Sweden. The platform is also developing preclinical formulations and performs bioanalytical services. The platform was formed in 2009 and is supported by a research group performing cutting edge research in the ADME drug delivery field.

UDOPP participates in the Innovative Medicine Initiative (IMI), New Drugs for Bad Bugs (ND4BB) program, European Gram Negative Antibacterial Engine (ENABLE) consortium and is also a part of the SciLifeLab Drug Discovery and Development Platform (SciLifeLab DDD). For more information, please visit the following homepages at ENABLE and UDOPP.

The ENABLE consortium includes 42 partners from academia and private pharmaceutical companies which creates a cross-European drug discovery engine for testing and optimizing molecules which have the potential to become future drug candidates capable of treating resistant gram-negative infections. The UDOPP team is responsible for all in vitro ADME investigations within the ENABLE consortium.

We are now recruiting a highly motivated and flexible bioanalysis scientist to expand our capacity. The position will be located at the Uppsala University Drug Optimization and Pharmaceutical Profiling Platform (UDOPP), Department of Pharmacy. Further information about the department and the research groups can be found at www.farmfak.uu.se/farm/.

Duties: The candidate will perform daily experimental work with physicochemical, in vitro ADME and cell based assays for small molecules, peptides and proteins. The successful candidate will analyze in vitro and in vivo samples using the LC-MS/MS technique and report the results to the respective project team. The candidate may also work as an ADME project team member in drug discovery projects within the ENABLE consortium.

Requirements: The successful candidate should have excellent laboratory skills including ability for planning, executing, analyzing and reporting of in vitro ADME results. Previous experience and knowledge about analytical techniques especially LC-MS/MS (including LC-HR/MS) is crucial. 

The successful candidate should also be flexible and highly motivated, have good problem solving and time management skills, and have the capacity to work with tight deadlines. Good interpersonal and cooperation skills and the ability to work in interdisciplinary teams are essential. The candidate should have a PhD degree or other relevant experience from the biotech/pharmaceutical industry or academic research settings.

Additional qualifications: Practical experience either from cell culture, immunology, and automated liquid handling systems is an advantage.

Uppsala University strives to be an inclusive workplace that promotes equal opportunities and attracts qualified candidates who can contribute to the University’s excellence and diversity. We welcome applications from all sections of the community and from people of all backgrounds.

Salary: Individual salary.

Starting date: 15-02-2020 or as otherwise agreed.

Type of employment: Temporary position ending 31-12-2020.

Scope of employment: 100%

For further information about the position please contact: Pawel Baranczewski, e-mail pawel.baranczewski@farmaci.uu.se, phone +46 (0)18 4714067 (office) or +46 (0) 707467894.

Please submit your application by 6 February 2020, UFV-PA 2019/4788.

Are you considering moving to Sweden to work at Uppsala University? If so, you will find a lot of information about working and living in Sweden at www.uu.se/joinus. You are also welcome to contact International Faculty and Staff Services at ifss@uadm.uu.se.